HLS Therapeutics Inc T.HLS

Alternate Symbol(s): HLTRF

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. The Vascepa (icosapent ethyl capsules) is a single-molecule prescription product in use to reduce the risk of cardiovascular events.

TSX:HLS - Post by User

HLS Therapeutics Inc

Bullboard Posts

Post by Bobwinson Jun 08, 2012 12:22pm

258 Views

Post# 19993560

Dividend money

Dividend money is showing up. I think some stockholders are using their dividend money to buy a few more shares. Nice positive action on low volume. Obviously insiders are trying to support share price.

Ex-insiders...........not so much.

Low volume means he's not selling today. May be the $210K he got will tide him over for a few days.

Bullboard Posts

@ the Bell: TSX advances to start off Christmas trading week